Stock listing

Frankfurt:MPV Medibank Private Ltd. Aktie

German listing (Frankfurt) of Medibank Private Ltd. · home listing ASX:MPL

Follow Medibank Private Ltd. into a list and get an email when it puts out news.

Share price · FWB:MPV

€3.14 EUR -0.02 (-0.6%)

Close on Nov 20, 2026

Past year +19.9% · daily closes, Nov 20, 2025 – Nov 6, 2026, adjusted for splits
Day range
€3.14 – €3.16 EURNov 20, 2026
Market cap
€8.65B EURAt the close on Nov 20, 2026 · price × 2.75B shares outstanding
52-week range
€2.48 – €3.20 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€252 EURMedian day 0 shares · 50 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026
Medibank Private Ltd. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
ASX:MPL · Home$5.27 AUD+0.02 (+0.4%)9,690,253$5.24$5.30$5.22$5.25Close on Nov 20, 2026
Frankfurt:MPV€3.14 EUR-0.02 (-0.6%)—€3.16€3.16€3.14€3.16Close on Nov 20, 2026
Munich:MPV€3.16 EUR-0.06 (-1.9%)—€3.20€3.20€3.16€3.22Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:MPV · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€3.163-0.023-0.7%€3.163€3.163€3.1630
€3.186+0.052+1.7%€3.189€3.189€3.1780
€3.134-0.025-0.8%€3.134€3.134€3.13420
€3.159+0.003+0.1%€3.159€3.159€3.1590
€3.156-0.04-1.3%€3.156€3.162€3.1290
€3.196+0.059+1.9%€3.196€3.196€3.1960
€3.137+0.073+2.4%€3.139€3.139€3.13580
€3.064-0.074-2.4%€3.064€3.064€3.0640
€3.138+0.019+0.6%€3.138€3.138€3.1380
€3.119+0.047+1.5%€3.119€3.119€3.1190
€3.072+0.035+1.2%€3.043€3.184€3.031,600
€3.037+0.036+1.2%€3.036€3.048€3.0360
€3.001+0.035+1.2%€2.994€3.01€2.9840
€2.966-0.028-0.9%€2.966€2.966€2.9660
€2.994+0.069+2.4%€2.912€3.004€2.8832,000
€2.925-0.004-0.1%€2.925€2.925€2.9250
€2.929+0.068+2.4%€2.949€2.969€2.9180
€2.861-0.019-0.7%€2.861€2.861€2.8610
€2.88+0.032+1.1%€2.88€2.88€2.880
€2.848+0.023+0.8%€2.848€2.848€2.8480
€2.825+0.033+1.2%€2.825€2.825€2.8254
€2.792-0.008-0.3%€2.792€2.792€2.7921,110
€2.80+0.004+0.1%€2.80€2.80€2.800
€2.796+0.029+1.0%€2.796€2.796€2.7960
€2.767+0.002+0.1%€2.78€2.783€2.7670
€2.765+0.055+2.0%€2.742€2.77€2.7410
€2.71-0.095-3.4%€2.71€2.71€2.710
€2.805+0.051+1.9%€2.805€2.805€2.8050
€2.754-0.021-0.8%€2.754€2.754€2.7540
€2.775+0.016+0.6%€2.775€2.775€2.7750
€2.759-0.013-0.5%€2.759€2.759€2.7590
€2.772-0.033-1.2%€2.772€2.772€2.7720
€2.805-0.027-1.0%€2.81€2.817€2.7780
€2.8320.000.0%€2.832€2.832€2.8320
€2.832+0.025+0.9%€2.832€2.834€2.7990
€2.807-0.027-1.0%€2.807€2.807€2.8070
€2.834+0.035+1.3%€2.837€2.837€2.8270
€2.799-0.061-2.1%€2.799€2.799€2.7990
€2.86+0.058+2.1%€2.86€2.86€2.860
€2.802-0.0010.0%€2.802€2.802€2.8020
€2.803+0.043+1.6%€2.803€2.835€2.790
€2.76-0.038-1.4%€2.76€2.76€2.760
€2.798-0.033-1.2%€2.798€2.798€2.7980
€2.831+0.012+0.4%€2.82€2.837€2.8160
€2.819-0.066-2.3%€2.819€2.819€2.8190
€2.885+0.036+1.3%€2.885€2.885€2.8850
€2.849-0.007-0.2%€2.849€2.849€2.8490
€2.856-0.082-2.8%€2.856€2.861€2.850
€2.938+0.004+0.1%€2.938€2.938€2.9380
€2.934+0.036+1.2%€2.934€2.934€2.9340
€2.898+0.013+0.5%€2.898€2.898€2.89814
€2.885-0.029-1.0%€2.885€2.885€2.8850
€2.914-0.006-0.2%€2.914€2.914€2.9140
€2.92+0.032+1.1%€2.92€2.92€2.920
€2.888-0.08-2.7%€2.888€2.889€2.8880
€2.968+0.207+7.5%€2.988€2.992€2.9540
€2.761-0.272-9.0%€2.761€2.761€2.7610
Ticker
Frankfurt:MPV
Asset type
Stock
Sector
Financials
Industry
Insurance
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

All Medibank Private Ltd. news

Medibank Private Ltd. on 6ix

Sector
Financials
Industry
Insurance
News releases
35 in the last 12 months · 133 in all · newest Nov 18, 2026 · oldest 2016
Calls
1 call with a replay · 1 with a transcript · latest Feb 18, 2026
Decks
41 decks · latest Aug 20, 2026

Where Medibank Private Ltd. is listed

ListingExchangeCountryCurrency
ASX:MPL · Home listingASXAustraliaAUD
OTC:MDBPFOTCUnited StatesUSD
gettex:MPVgettexGermanyEUR
LS Exchange:A12D1WLS ExchangeGermanyEUR
Lang & Schwarz:A12D1WLang & SchwarzGermanyEUR
Frankfurt:MPV · This pageFrankfurtGermanyEUR
Dusseldorf:MPVDusseldorfGermanyEUR
BX Swiss:MPVBX SwissSwitzerlandCHF
Munich:MPVMunichGermanyEUR
Tradegate:MPVTradegateGermanyEUR
OTC:MDBKYOTCUnited StatesUSD

Valuation

P/E 22.7× against a median of 11.7×: 9th lowest of 10 Insurance companies shown. Statements: Year to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$13.91B AUD
P/E
22.7×
EV/sales
1.5×
EV/EBITDA
13.5×
Price/book
6.0×
Gross margin
17.2%
Operating margin
10.0%
Net margin
6.9%
Debt to equity
0.1×
Beta
No index for this market yet

Insurance: the 10 companies nearest in size, of 258 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Medibank Private Ltd. · ASX:MPLUS$9.61BUS$9.21B22.7×1.5×13.5×6.0×6.9%0.1×n/a
Harel Insurance Investments & Financial Services Ltd. · TASE:HARLUS$10.86BUS$9.39B11.1×1.0×5.8×2.9×10.6%2.1×n/a
Molina Healthcare Inc · NYSE:MOHUS$10.36BUS$5.55Bn/a0.1×16.7×2.5×−0.1%0.9×0.10
Vienna Insurance Group AG · VIE:VIGUS$10.32B−US$19.28B10.2×−1.2×−6.1×1.3×6.4%0.3×n/a
Discovery Limited · JSE:DSYUS$9.96BUS$9.86B13.2×1.9×8.3×2.1×14.4%0.2×n/a
Old Republic International Corporation · NYSE:ORIUS$9.64BUS$9.30B8.8×0.9×n/a1.6×11.2%0.0×-0.14
ICICI Lombard General Insurance Co. Ltd. · NSE:ICICIGIUS$9.36BUS$9.30B34.0×3.0×n/a4.6×8.8%0.0×n/a
Kinsale Capital Group, Inc. · NYSE:KNSLUS$8.97BUS$9.04B17.1×4.6×n/a4.7×26.9%0.1×-0.21
Primerica, Inc. · NYSE:PRIUS$8.83BUS$4.76B11.1×1.4×4.6×3.1×22.8%0.0×0.19
Menora Mivtachim Holdings Ltd. · TASE:MMHDUS$8.69BUS$10.15B11.7×2.0×9.2×3.0×14.4%0.7×n/a
Storebrand ASA · OSL:STBUS$8.55BUS$13.47B18.6×1.5×n/a2.5×5.1%1.8×n/a
Median of the othersUS$9.50BUS$9.30B11.7×1.4×7.0×2.7×10.9%0.3×-0.02

Forecasts

Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.

Price target
5.06 AUD · Analysts' mean
EPS, year to Jun 2027
0.25 · 9 analysts
Revenue, year to Jun 2027
9.64B · 5 analysts

Team and board

Officers

OfficerRole
Andrew WilsonGroup Lead – Chief Executive Amplar Health
David KoczkarChief Executive Officer
Mark RogersGroup Lead – Chief Financial Officer & Group Strategy
Mei RamsayGroup Lead – Trust, Legal & Company Secretariat and Company Secretary
Milosh MilisavljevicGroup Lead – Chief Customer Officer
Rachel StockGroup Lead – Chief Risk Officer

Board

DirectorRole
Mike WilkinsChair and Independent Non-executive Director
Gerard DalboscoIndependent Non-executive Director
Jacqueline HeyIndependent Non-executive Director
Kathryn Fagg ACIndependent Non-executive Director
Lisa McIntyreIndependent Non-executive Director
Peter EveringhamIndependent Non-executive Director

Events

Next results
Feb 18, 2027 (expected)

Calls

CallWhenStatus
Medibank Private (ASX:MPL) Q2 2026 Earnings CallWed, Feb 18, 2026 · 5:30 PM ETReplay

Results days

QuarterResultsShare move
Q2 2026Feb 19, 2026−6.7%
Quarter to Sep 30, 2025Dec 3, 2025−2.2%
Q4 2025Aug 28, 2025 · Before open−2.5%
Quarter to Mar 31, 2025May 28, 2025−0.4%
Q2 2025Feb 26, 2025+10.2%
Quarter to Sep 30, 2024Nov 27, 2024+1.6%
Q4 2024Aug 21, 2024−3.0%
Quarter to Mar 31, 2024May 29, 2024+0.3%
Q2 2024Feb 22, 2024−6.0%
Quarter to Sep 30, 2023Nov 29, 20230.0%
All 18 quarters
QuarterResultsShare move
Q4 2023Aug 24, 2023 · After close+1.7%
Q3 2023May 31, 2023+2.0%
Q2 2023Feb 23, 2023 · After close+2.1%
Q1 2023Nov 30, 2022+2.4%
Q4 2022Aug 18, 2022 · Before open+0.8%
Q2 2022Feb 24, 2022 · After close−3.8%
Q4 2021Aug 24, 2021−1.1%
Q2 2021Feb 24, 2021−4.2%

Open Events

Decks

DeckKindSlidesDate
FY2026 Earnings PresentationEarnings37 slidesAug 20, 2026
Investor Presentation (February 2026)Investor deck37 slidesFeb 19, 2026
Investor Presentation (October 2025)Investor deck57 slidesOct 29, 2025
FY2025 Earnings PresentationEarnings38 slidesAug 28, 2025
Investor Presentation (February 2025)Investor deck37 slidesFeb 27, 2025
Australian Shareholders' Association Engage Event 2024Conference8 slidesOct 3, 2024
FY2024 Earnings PresentationEarnings40 slidesAug 22, 2024
Investor Presentation (February 2024)Investor deck36 slidesFeb 22, 2024
FY2023 Earnings PresentationEarnings37 slidesAug 24, 2023
Macquarie Australia Conference 2023Conference14 slidesMay 2, 2023
All 41 decks
DeckKindSlidesDate
Investor Presentation (February 2023)Investor deck36 slidesFeb 23, 2023
FY2022 Earnings PresentationEarnings39 slidesAug 18, 2022
Macquarie Australia Conference 2022Conference10 slidesMay 3, 2022
Investor Presentation (February 2022)Investor deck35 slidesFeb 25, 2022
FY2021 Earnings PresentationEarnings35 slidesAug 25, 2021
Macquarie Australia Conference 2021Conference8 slidesMay 5, 2021
Investor Presentation (February 2021)Investor deck34 slidesFeb 24, 2021
FY2020 Earnings PresentationEarnings34 slidesAug 20, 2020
Macquarie Australia Conference 2020Conference8 slidesMay 6, 2020
Investor Presentation (February 2020)Investor deck33 slidesFeb 20, 2020
FY2019 Earnings PresentationEarnings33 slidesAug 22, 2019
Macquarie Australia Conference 2019Conference15 slidesApr 30, 2019
Investor Presentation (February 2019)Investor deck33 slidesFeb 15, 2019
FY2018 Earnings PresentationEarnings38 slidesAug 24, 2018
Macquarie Australia Conference 2018Conference23 slidesMay 1, 2018
1H18 Earnings PresentationEarnings36 slidesFeb 16, 2018
FY2017 Earnings PresentationEarnings36 slidesAug 25, 2017
Macquarie Australia Conference 2017Conference14 slidesMay 2, 2017
Morgan Stanley Private Health Forum 2017Conference15 slidesApr 5, 2017
H1 2017 Earnings PresentationEarnings34 slidesFeb 17, 2017
Investor Day (November 2016)Investor day43 slidesNov 30, 2016
FY2016 Earnings PresentationEarnings33 slidesAug 19, 2016
Fact Sheet (June 2016)Fact sheet3 slidesJune 2016
Macquarie Australia Conference 2016Conference17 slidesMay 6, 2016
H1 2016 Earnings PresentationEarnings36 slidesFeb 19, 2016
Investor Day (October 2015)Investor day86 slidesOct 27, 2015
Shareholder Meeting (October 2015)Shareholder meeting23 slidesOct 21, 2015
FY2015 Earnings PresentationEarnings37 slidesAug 21, 2015
Macquarie Australia Conference 2015Conference21 slidesMay 8, 2015
H1 2015 Earnings PresentationEarnings28 slidesFeb 20, 2015
CEPAR (July 2013)Conference53 slidesJul 4, 2013

Open Decks

Financials

Annual, in AUD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue9.33B8.56B8.02B7.40B7.09B6.98B6.83B6.76B6.58B6.95B
Cost of revenue7.72B-8.10M5.86B5.68B5.56B5.32B5.20B5.15B
Gross profit1.60B8.56B8.02B7.40B7.10B7.03B6.83B6.76B6.58B6.95B
Selling, general and administrative63.4M1.05B754.6M671.0M666.1M664.5M648.8M619.6M942.7M915.6M
Operating income927.9M7.90B7.00B442.5M557.9M6.32B453.6M616.3M598.4M628.7M
Depreciation and amortization105.1M96.0M89.4M40.7M41.2M45.1M49.2M104.3M95.3M85.5M
EBITDA1.03B8.00B7.09B483.2M599.1M6.36B502.8M720.6M693.7M714.2M
Interest expense15.8M11.0M5.40M1.80M2.40M2.80M3.40M000
Income before tax927.9M728.8M711.7M437.9M560.0M633.3M450.2M616.3M598.4M628.7M
Income tax281.6M219.5M215.3M129.3M166.1M191.1M134.6M178.6M174.2M179.2M
Net income638.7M500.8M492.5M511.1M393.9M441.2M315.0M458.7M445.1M449.5M
Earnings per share, basic0.230.180.180.190.140.160.110.170.160.16

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents570.4M648.6M691.0M420.6M596.7M671.7M871.4M656.5M470.1M594.6M
Short-term investments306.0M225.3M236.9M2.87B2.85B2.31B1.99B2.13B2.28B2.04B
Receivables105.7M66.4M39.5M248.1M225.4M215.9M207.1M283.9M292.2M317.0M
Inventory-967.4M-668.7M-822.1M-887.6M-1.08B-3.35B-3.33B-3.27B
Current assets570.4M3.78B4.75B3.63B3.68B3.21B3.07B656.5M470.1M594.6M
Property, plant and equipment194.2M205.0M70.5M88.4M101.7M112.2M49.3M53.6M87.3M
Goodwill507.3M342.4M323.7M204.5M204.5M204.5M204.5M204.5M141.2M107.3M
Total assets4.75B4.70B4.69B4.39B4.55B3.92B3.75B3.63B3.54B3.46B
Accounts payable262.4M205.9M163.8M215.7M241.4M239.9M230.2M275.6M259.8M246.9M
Current liabilities2.01B2.00B1.31B1.60B1.04B1.07B45.6M43.3M34.1M
Long-term debt35.9M
Total debt273.9M209.0M218.3M55.3M76.9M93.4M109.2M
Total liabilities2.34B2.36B2.38B2.30B2.61B2.02B1.95B45.6M43.3M34.1M
Shareholders' equity2.43B2.34B2.31B2.08B1.95B1.91B1.80B1.94B1.83B1.72B
Shares outstanding2.75B2.75B2.75B2.75B2.75B2.75B2.75B2.75B2.75B2.75B

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations622.5M380.9M868.5M184.5M948.5M482.2M572.4M416.1M408.3M393.4M
Capital spending-19.4M-11.2M-57.6M-41.9M-35.1M-35.1M-29.3M-9.80M-3.80M-5.50M
Free cash flow603.1M369.7M810.9M142.6M913.4M447.1M543.1M406.3M404.5M387.9M
Cash from investing-120.8M110.5M-110.8M58.5M-623.6M-306.1M109.2M129.1M-190.8M75.9M
Cash from financing-579.9M-533.8M-487.3M-419.1M-399.9M-375.8M-466.7M-358.8M-342.0M-313.4M
Dividends paid-509.5M-473.7M-426.9M-374.5M-358.0M-333.2M-429.6M-355.3M-337.4M-309.8M
Share buybacks-10.7M-6.40M-7.50M-4.90M-3.10M-5.60M-3.80M-3.50M-4.60M-3.60M
Change in cash-78.2M-42.4M270.4M-176.1M-75.0M-199.7M214.9M186.4M-124.5M155.9M

Open Financials

Filings

FilingDateTypeFiled with
Results of 2026 Annual General MeetingNov 17, 2026Meeting outcomeASX
2026 AGM Chair and CEO addressNov 17, 2026Meeting outcomeASX
Proxy Form 2026Oct 8, 2026Proxy formASX
Notice of Annual General Meeting 2026Oct 8, 2026Meeting noticeASX
Becoming a substantial holderOct 1, 2026Ownership change noticeASX
Ceasing to be a substantial holderSep 30, 2026Ownership change noticeASX
Becoming a substantial holderSep 29, 2026Ownership change noticeASX
Ceasing to be a substantial holderSep 28, 2026Ownership change noticeASX
Becoming a substantial holderSep 22, 2026Ownership change noticeASX
Ceasing to be a substantial holderSep 21, 2026Ownership change noticeASX
All 115 filings
FilingDateTypeFiled with
Dr Tracey Batten to retire as Medibank Board directorSep 20, 2026Other filingsASX
Appendix 4G 2026Sep 15, 2026Other filingsASX
Corporate Governance Statement 2026Sep 15, 2026Other filingsASX
Annual Report 2026Sep 15, 2026Annual reportASX
Notification of cessation of securities - MPLSep 7, 2026FinancingASX
Notification regarding unquoted securities - MPLSep 6, 2026Other filingsASX
Change of Director’s InterestSep 6, 2026Management or board changeASX
Notification of cessation of securities - MPLSep 3, 2026FinancingASX
Change of Director's Interest - Peter EveringhamSep 1, 2026Management or board changeASX
Change of Director's Interest - Jacqueline HeyAug 26, 2026Management or board changeASX
FY26 Results - Investor PresentationAug 19, 2026Other filingsASX
FY26 Results - Media ReleaseAug 19, 2026Other filingsASX
FY26 Appendix 4E, Financial Report and Sustainability ReportAug 19, 2026ResultsASX
Dividend/Distribution - MPLAug 19, 2026DividendASX
HY26 Results - Investor PresentationFeb 18, 2026Other filingsASX
HY26 Results - Media ReleaseFeb 18, 2026Other filingsASX
HY26 Results - Appendix 4D and Financial ReportFeb 18, 2026Interim reportASX
Medibank to acquire Better MedicalNov 4, 2025Acquisition or disposalASX
Medibank sets new ambition in healthOct 28, 2025Other filingsASX
FY25 Results - Investor PresentationAug 27, 2025Other filingsASX
FY25 Results - Appendix 4E and Financial ReportAug 27, 2025ResultsASX
FY25 Results - Media ReleaseAug 27, 2025Other filingsASX
HY25 Results - Media ReleaseFeb 26, 2025Other filingsASX
HY25 Results - Investor PresentationFeb 26, 2025Other filingsASX
HY25 Results - Appendix 4D and Financial ReportFeb 26, 2025Interim reportASX
FY24 Results - Investor PresentationAug 21, 2024Other filingsASX
FY24 Results - Media ReleaseAug 21, 2024Other filingsASX
FY24 Results - Appendix 4E and Financial ReportAug 21, 2024ResultsASX
HY24 Results - Investor PresentationFeb 21, 2024Other filingsASX
HY24 Results - Media ReleaseFeb 21, 2024Other filingsASX
HY24 Results - Appendix 4D and Financial ReportFeb 21, 2024Interim reportASX
FY23 Results - Investor PresentationAug 23, 2023Other filingsASX
FY23 Results - Appendix 4E and Financial ReportAug 23, 2023ResultsASX
FY23 Results - Media ReleaseAug 23, 2023Other filingsASX
Medibank response to APRA announcementJun 26, 2023Other filingsASX
Macquarie Conference Presentation and FY23 Outlook updateMay 1, 2023GuidanceASX
HY23 Results - Investor PresentationFeb 22, 2023Other filingsASX
HY23 Results - Media ReleaseFeb 22, 2023Other filingsASX
HY23 Results - Appendix 4D and Financial ReportFeb 22, 2023Interim reportASX
Medibank announces 2023 premium increase & premium deferralFeb 6, 2023Other filingsASX
Medibank cybercrime updateNov 6, 2022Other filingsASX
Reinstatement to Official QuotationOct 25, 2022Trading halt or suspensionASX
Medibank cybercrime, business and FY23 outlook updateOct 25, 2022GuidanceASX
Suspension from Official QuotationOct 21, 2022Trading halt or suspensionASX
Medibank cyber incident update responseOct 20, 2022Other filingsASX
Medibank cyber incident updateOct 19, 2022Other filingsASX
Trading HaltOct 19, 2022Trading halt or suspensionASX
Pause in TradingOct 19, 2022Trading halt or suspensionASX
Medibank cyber incident and trading updateOct 16, 2022Other filingsASX
Medibank cyber incidentOct 13, 2022Other filingsASX
FY22 Results - Appendix 4E and Financial ReportAug 17, 2022ResultsASX
FY22 Results - Investor PresentationAug 17, 2022Other filingsASX
FY22 Results - Media ReleaseAug 17, 2022Other filingsASX
HY22 Results - Appendix 4D and Financial ReportFeb 24, 2022Interim reportASX
HY22 Results - Investor PresentationFeb 24, 2022Other filingsASX
HY22 Results - Media ReleaseFeb 24, 2022Other filingsASX
Medibank announces 2022 premium & give back of around $135mDec 22, 2021Other filingsASX
FY21 Results - Investor PresentationAug 24, 2021Other filingsASX
FY21 Results - Appendix 4E and Financial ReportAug 24, 2021ResultsASX
FY21 Results - Media ReleaseAug 24, 2021Other filingsASX
David Koczkar appointed Medibank CEOApr 18, 2021Other filingsASX
HY21 Results - Investor PresentationFeb 23, 2021Other filingsASX
HY21 Results - Media ReleaseFeb 23, 2021Other filingsASX
Medibank announces Craig Drummond to retire as CEOFeb 23, 2021Other filingsASX
HY21 Results - Appendix 4D and Financial ReportFeb 23, 2021Interim reportASX
FY20 Results - Investor PresentationAug 19, 2020Other filingsASX
FY20 Results - Media ReleaseAug 19, 2020Other filingsASX
FY20 Results - Appendix 4E & Financial ReportAug 19, 2020ResultsASX
HY20 Results - Investor PresentationFeb 19, 2020Other filingsASX
HY20 Results - Media ReleaseFeb 19, 2020Other filingsASX
HY20 Results - Appendix 4D and Financial ReportFeb 19, 2020Interim reportASX
Medibank provides update on outlook for FY20Nov 5, 2019GuidanceASX
Medibank and ahm response to ACCC proceedingsSep 2, 2019Other filingsASX
FY19 Results - Investor PresentationAug 21, 2019Other filingsASX
FY19 Results - Media ReleaseAug 21, 2019Other filingsASX
FY19 Results - Appendix 4E & Financial ReportAug 21, 2019ResultsASX
HY19 Results - Investor PresentationFeb 14, 2019Other filingsASX
HY19 Results - Media ReleaseFeb 14, 2019Other filingsASX
HY19 Results - Appendix 4D and Financial ReportFeb 14, 2019Interim reportASX
Medibanks average premium increase lowest in 18 yearsDec 18, 2018Other filingsASX
Garrison Health Services contract updateNov 19, 2018Other filingsASX
FY18 Results - Investor PresentationAug 23, 2018Other filingsASX
FY18 Results - Media Release - Medibank back on trackAug 23, 2018Other filingsASX
FY18 Results - Appendix 4E & Financial ReportAug 23, 2018ResultsASX
Presentation to Macquarie Australia Conference - 2 May 2018Apr 30, 2018Other filingsASX
HY18 Results - Appendix 4D & Financial ReportFeb 15, 2018Interim reportASX
KGN: Kogan.com signs with Medibank to launch Kogan HealthDec 11, 2017Other filingsASX
Medibank to defend ACCC appealSep 20, 2017Other filingsASX
Federal Court dismissed ACCC proceedings against MedibankAug 30, 2017Legal or regulatory actionASX
FY17 Results - Appendix 4E & Financial ReportAug 24, 2017ResultsASX
HY 17 Results - Appendix 4D & Financial ReportFeb 16, 2017Interim reportASX
Medibank announces approved average premium increaseFeb 9, 2017Other filingsASX
AGM - Chairman and MD Presentations and FY17 Outlook UpdateNov 8, 2016GuidanceASX
FY16 Results - App 4E, Directors Report & Financial ReportAug 18, 2016Other filingsASX
Admission to Official ListMar 30, 2016Other filingsASX
Medibank appoints Craig Drummond as MD and CEOMar 28, 2016Other filingsASX
2016 Premium changes approved by Federal GovernmentMar 1, 2016Other filingsASX
HY 16 Results - App 4D & Financial ReportFeb 18, 2016Other filingsASX
Update to FY16 Health Insurance Financial TargetsFeb 11, 2016Other filingsASX
Retirement of Managing DirectorFeb 11, 2016Management or board changeASX
FY15 Results - App 4E, Directors Report & Financial ReportFeb 11, 2016Other filingsASX
S&P DJ Indices Announces March Quarterly ReviewFeb 11, 2016Other filingsASX
Premium changes approved by Federal GovernmentFeb 11, 2016Other filingsASX
Half Year Results AnnouncementFeb 11, 2016Interim reportASX
Half Year ResultsFeb 11, 2016Interim reportASX

Open Filings

Cap table

Built by 6ix from Medibank Private Ltd.’s releases

Common shares
2,754,003,240
Fully diluted
2,754,003,240

Fully diluted

LineShares
Common shares2,754,003,240

Share count over time

CountShares
Nov 22, 20262,754,003,240

Open Cap table

Shareholders

HolderSharesValueAs of
Vanguard Total International Stock Index Fund40.7MUS$148MJul 31, 2026
Vanguard Developed Markets Index Fund26.9MUS$92.5MJun 30, 2026
iShares Core MSCI EAFE ETF20.5MUS$74.3MJul 31, 2026
Fidelity SAI International Low Volatility Index Fund13.7MUS$49.6MJul 31, 2026
Fidelity International Index Fund10.4MUS$35.8MMay 31, 2026
JPMorgan International Research Enhanced Equity ETF10MUS$36.4MJul 31, 2026
Capital Income Builder9.98MUS$36.3MJul 31, 2026
iShares MSCI EAFE Min Vol Factor ETF9.89MUS$35.9MJul 31, 2026
iShares MSCI EAFE ETF9.46MUS$34.3MJul 31, 2026
JPMorgan International Equity Fund9.27MUS$33.6MJul 31, 2026
Show 50 holders
HolderSharesValueAs of
JPMorgan BetaBuilders Developed Asia Pacific ex-Japan ETF8.24MUS$29.9MJul 31, 2026
Vanguard Ftse All-World Ex-Us Index Fund6.6MUS$23.9MJul 31, 2026
iShares MSCI Intl Quality Factor ETF6.24MUS$22.6MJul 31, 2026
Schwab International Equity ETF6.01MUS$20.7MMay 31, 2026
Fidelity Series Global ex U.S. Index Fund5.43MUS$19.7MJul 31, 2026
Fidelity SAI Global ex U.S. Low Volatility Index Fund5.29MUS$19.2MJul 31, 2026
Nuveen International Equity Index Fund4.39MUS$15.9MJul 31, 2026
iShares MSCI EAFE Growth ETF4.23MUS$15.3MJul 31, 2026
Vanguard Global Minimum Volatility Fund3.92MUS$14.2MJul 31, 2026
International Core Equity 2 Portfolio3.89MUS$14.1MJul 31, 2026
iShares Core MSCI Total International Stock ETF3.67MUS$13.3MJul 31, 2026
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF3.29MUS$11.3MJun 30, 2026
Vanguard International High Dividend Yield Index Fund3.11MUS$11.3MJul 31, 2026
Avantis International Equity ETF2.99MUS$10.3MMay 31, 2026
Vanguard Pacific Stock Index Fund2.98MUS$10.8MJul 31, 2026
iShares Core MSCI International Developed Markets ETF2.85MUS$10.3MJul 31, 2026
iShares MSCI Australia ETF2.79MUS$9.59MMay 31, 2026
Dimensional International High Profitability ETF2.7MUS$9.8MJul 31, 2026
AB International Low Volatility Equity ETF2.69MUS$9.29MMay 31, 2026
iShares MSCI Pacific ex Japan ETF2.57MUS$8.84MMay 31, 2026
Schwab Fundamental International Equity ETF2.24MUS$7.74MMay 31, 2026
Vanguard Total World Stock Index Fund2.18MUS$7.92MJul 31, 2026
College Retirement Equities Fund - Total Global Stock Account1.98MUS$6.82MJun 30, 2026
State Street(R) SPDR(R) S&P(R) International Dividend ETF1.86MUS$6.4MJun 30, 2026
Schwab International Index Fund1.84MUS$6.67MJul 31, 2026
Dimensional International Core Equity Market ETF1.83MUS$6.64MJul 31, 2026
iShares MSCI EAFE International Index Fund1.74MUS$5.99MJun 30, 2026
Strategic Advisers International Fund1.62MUS$5.59MMay 31, 2026
Fidelity Total International Index Fund1.59MUS$5.77MJul 31, 2026
Xtrackers MSCI EAFE High Dividend Yield Equity ETF1.5MUS$5.19MMay 29, 2026
International Growth and Income Fund1.5MUS$5.16MJun 30, 2026
Fidelity Global ex U.S. Index Fund1.44MUS$5.23MJul 31, 2026
Old Westbury Small & Mid Cap Strategies Fund1.25MUS$4.55MJul 31, 2026
Invesco International Developed Dynamic Multifactor ETF1.19MUS$4.09MMay 31, 2026
Fidelity SAI International Quality Index Fund1.17MUS$4.22MJul 31, 2026
Fidelity SAI International Index Fund1.15MUS$4.18MJul 31, 2026
Harbor Osmosis International Resource Efficient ETF1.13MUS$4.09MJul 31, 2026
Xtrackers MSCI EAFE Hedged Equity ETF1.08MUS$3.74MMay 29, 2026
Dimensional International Core Equity 2 ETF1.08MUS$3.92MJul 31, 2026
Harbor International Core Fund1.04MUS$3.76MJul 31, 2026

This page holds 50 of 233 holders. Open Shareholders

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Andrew WilsonGroup Lead – Chief Executive Amplar Health · Since at least Oct 21, 2025
David KoczkarChief Executive Officer · Since at least Sep 17, 2026
Gerard DalboscoIndependent Non-executive Director · Since at least Nov 5, 2026
Jacqueline HeyIndependent Non-executive Director · Since at least Aug 26, 2026
Kathryn Fagg ACIndependent Non-executive Director · Since at least Nov 5, 2026
Lisa McIntyreIndependent Non-executive Director · Since at least Nov 5, 2026
Mark RogersGroup Lead – Chief Financial Officer & Group Strategy · Since at least Nov 5, 2026
Mei RamsayGroup Lead – Trust, Legal & Company Secretariat and Company Secretary · Since at least Nov 5, 2026
Mike WilkinsChair and Independent Non-executive Director · Since at least Sep 17, 2026
Milosh MilisavljevicGroup Lead – Chief Customer Officer · Since at least Jan 13, 2026
All 13 people
PersonSeat
Peter EveringhamIndependent Non-executive Director · Since at least Sep 1, 2026
Rachel StockGroup Lead – Chief Risk Officer · Since at least Nov 5, 2026
Tracey BattenIndependent Non-executive Director · Sep 20, 2026 – Sep 20, 2026 · Past

Open People

Log in to ask 6ix AI your own questions about Medibank Private Ltd.